The UK's energy partner.

Learn more at equinore.

Good morning from the newsroom of the Financial Times.

Today is Thursday, September 12th. Good morning from the newsroom of the Financial Times.

Today is Thursday, September 12th,

and this is your FT news briefing.

Purdue Pharma has reached a tentative deal

with several US states to resolve legal claims stemming from the

opioid crisis. The Pentagon is compiling a list of companies with ties to the

Chinese military and after refusing for months to release the Operation Yellow Hammer plan, the UK government

has made a document that outlines the potential effects of a no-deal Brexit public.

Plus, the FT's Philip Stafford explains why investors have given a cold

shoulder to Hong Kong's 32 billion pound bid for the London Stock Exchange.

I'm Mark Filipino and here's the news you need to start your day.

On Wednesday, Purdue Pharma and members of the controlling Sackler family struck a preliminary

deal with several U.S US states and local governments.

This came as the company tried to resolve legal claims stemming from the American opioid crisis.

But some places like New York wouldn't come to the table.

The F.T's Pharmaceutical and biotech reporter Hannah Cushler has more.

So we've been waiting for Purdue Pharma, which is the maker of OxyContin,

this incredibly powerful opioid and the family that

controls it the Sackler family to settle the vast number of lawsuits that they

...